[PS] Plenary Session

[PS-2] Long-term efficacy of gene therapy for AADC deficiency, including patients with a moderate phenotype.

^○Marina Mizobe^1,6, Karin Kojima¹, Kohei Nagai¹, Tadahiro Mitani¹, Kazuhiro Muramatsu¹, Hitoshi Osaka¹, Naoyuki Taga², Masahiro Hirai³, Yoshiyuki Onuki⁴, Takeshi Nakajima⁴, Shin-ichi Muramatsu⁵, Takanori Yamagata¹ (1.Department of Pediatrics, Jichi Medical University, 2.Department of Anesthesiology and Critical Care Medicine, Division of Anesthesiology, Jichi Medical University, 3.Department of Cognitive and Psychological Sciences, Nagoya University, 4.Department of Neurosurgery, Jichi Medical University, 5.Division of Neurological Gene Therapy, Jichi Medical University, 6.Department of Pediatrics, Yokohama Rosai Hospital)